Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Insulin resistance, diabetes mellitus, and brain structure in bipolar disorders

T. Hajek, C. Calkin, R. Blagdon, C. Slaney, R. Uher, M. Alda,

. 2014 ; 39 (12) : 2910-8. [pub] 20140619

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

E-resources Online Full text

NLK Free Medical Journals from 1994 to 1 year ago
PubMed Central from 2010 to 1 year ago
Europe PubMed Central from 2010 to 1 year ago
ProQuest Central from 2000-01-01 to 2017-12-31
Open Access Digital Library from 1994-01-01
Medline Complete (EBSCOhost) from 2004-06-01 to 2015-12-02
Health & Medicine (ProQuest) from 2000-01-01 to 2017-12-31
Psychology Database (ProQuest) from 2000-01-01 to 2017-12-31

Type 2 diabetes mellitus (T2DM) damages the brain, especially the hippocampus, and frequently co-occurs with bipolar disorders (BD). Reduced hippocampal volumes are found only in some studies of BD subjects and may thus be secondary to the presence of certain clinical variables. Studying BD patients with abnormal glucose metabolism could help identify preventable risk factors for hippocampal atrophy in BD. We compared brain structure using optimized voxel-based morphometry of 1.5T MRI scans in 33 BD subjects with impaired glucose metabolism (19 with insulin resistance/glucose intolerance (IR/GI), 14 with T2DM), 15 euglycemic BD participants and 11 euglycemic, nonpsychiatric controls. The group of BD patients with IR, GI or T2DM had significantly smaller hippocampal volumes than the euglycemic BD participants (corrected p=0.02) or euglycemic, nonpsychiatric controls (corrected p=0.004). Already the BD subjects with IR/GI had smaller hippocampal volumes than euglycemic BD participants (t(32)=-3.15, p=0.004). Age was significantly more negatively associated with hippocampal volumes in BD subjects with IR/GI/T2DM than in the euglycemic BD participants (F(2, 44)=9.96, p=0.0003). The gray matter reductions in dysglycemic subjects extended to the cerebral cortex, including the insula. In conclusion, this is the first study demonstrating that T2DM or even prediabetes may be risk factors for smaller hippocampal and cortical volumes in BD. Abnormal glucose metabolism may accelerate the age-related decline in hippocampal volumes in BD. These findings raise the possibility that improving diabetes care among BD subjects and intervening already at the level of prediabetes could slow brain aging in BD.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15031934
003      
CZ-PrNML
005      
20151014102425.0
007      
ta
008      
151005s2014 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/npp.2014.148 $2 doi
035    __
$a (PubMed)25074491
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Hajek, Tomas $u 1] Department of Psychiatry, Dalhousie University, Halifax, NS, Canada [2] Prague Psychiatric Center, Department of Psychiatry and Medical Psychology, 3rd School of Medicine, Charles University, Prague, Czech Republic.
245    10
$a Insulin resistance, diabetes mellitus, and brain structure in bipolar disorders / $c T. Hajek, C. Calkin, R. Blagdon, C. Slaney, R. Uher, M. Alda,
520    9_
$a Type 2 diabetes mellitus (T2DM) damages the brain, especially the hippocampus, and frequently co-occurs with bipolar disorders (BD). Reduced hippocampal volumes are found only in some studies of BD subjects and may thus be secondary to the presence of certain clinical variables. Studying BD patients with abnormal glucose metabolism could help identify preventable risk factors for hippocampal atrophy in BD. We compared brain structure using optimized voxel-based morphometry of 1.5T MRI scans in 33 BD subjects with impaired glucose metabolism (19 with insulin resistance/glucose intolerance (IR/GI), 14 with T2DM), 15 euglycemic BD participants and 11 euglycemic, nonpsychiatric controls. The group of BD patients with IR, GI or T2DM had significantly smaller hippocampal volumes than the euglycemic BD participants (corrected p=0.02) or euglycemic, nonpsychiatric controls (corrected p=0.004). Already the BD subjects with IR/GI had smaller hippocampal volumes than euglycemic BD participants (t(32)=-3.15, p=0.004). Age was significantly more negatively associated with hippocampal volumes in BD subjects with IR/GI/T2DM than in the euglycemic BD participants (F(2, 44)=9.96, p=0.0003). The gray matter reductions in dysglycemic subjects extended to the cerebral cortex, including the insula. In conclusion, this is the first study demonstrating that T2DM or even prediabetes may be risk factors for smaller hippocampal and cortical volumes in BD. Abnormal glucose metabolism may accelerate the age-related decline in hippocampal volumes in BD. These findings raise the possibility that improving diabetes care among BD subjects and intervening already at the level of prediabetes could slow brain aging in BD.
650    _2
$a dospělí $7 D000328
650    _2
$a stárnutí $x patologie $7 D000375
650    _2
$a bipolární porucha $x komplikace $x metabolismus $x patologie $7 D001714
650    _2
$a mozek $x patologie $7 D001921
650    _2
$a průřezové studie $7 D003430
650    _2
$a diabetes mellitus 2. typu $x komplikace $x patologie $7 D003924
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a porucha glukózové tolerance $7 D018149
650    _2
$a lidé $7 D006801
650    _2
$a počítačové zpracování obrazu $7 D007091
650    12
$a inzulinová rezistence $7 D007333
650    _2
$a magnetická rezonanční tomografie $7 D008279
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a velikost orgánu $7 D009929
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Calkin, Cynthia $u Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
700    1_
$a Blagdon, Ryan $u Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
700    1_
$a Slaney, Claire $u Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
700    1_
$a Uher, Rudolf $u Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
700    1_
$a Alda, Martin $u 1] Department of Psychiatry, Dalhousie University, Halifax, NS, Canada [2] Prague Psychiatric Center, Department of Psychiatry and Medical Psychology, 3rd School of Medicine, Charles University, Prague, Czech Republic. $7 xx0072985
773    0_
$w MED00006658 $t Neuropsychopharmacology official publication of the American College of Neuropsychopharmacology $x 1740-634X $g Roč. 39, č. 12 (2014), s. 2910-8
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25074491 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20151005 $b ABA008
991    __
$a 20151014102616 $b ABA008
999    __
$a ok $b bmc $g 1092810 $s 915060
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 39 $c 12 $d 2910-8 $e 20140619 $i 1740-634X $m Neuropsychopharmacology $n Neuropsychopharmacology $x MED00006658
LZP    __
$a Pubmed-20151005

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...